116 related articles for article (PubMed ID: 25805087)
21. Treatment of pulmonary hypertension in interstitial lung disease: do not throw out the baby with the bath water.
Cottin V
Eur Respir J; 2013 Apr; 41(4):781-3. PubMed ID: 23543646
[No Abstract] [Full Text] [Related]
22. First-in-class guanylate cyclase stimulator approved for PAH.
Guha M
Nat Biotechnol; 2013 Dec; 31(12):1064. PubMed ID: 24316627
[No Abstract] [Full Text] [Related]
23. [Pulmonary hypertension--diagnostic and current concepts].
Tröster N; Kovacs G; Olschewski H
MMW Fortschr Med; 2014 Apr; 156(7):49-52; quiz 53. PubMed ID: 24956659
[No Abstract] [Full Text] [Related]
24. New insights into pulmonary hypertension.
Furlow B
Lancet Respir Med; 2013 Sep; 1(7):508. PubMed ID: 24461605
[No Abstract] [Full Text] [Related]
25. Riociguat recommended by CHMP for approval in the EU for use in two forms of pulmonary hypertension.
Dowdall M
Future Cardiol; 2014 Mar; 10(2):163. PubMed ID: 24883440
[No Abstract] [Full Text] [Related]
26. [Pulmonary arterial hypertension--a rare form of pulmonary hypertension].
Schenk M
Dtsch Med Wochenschr; 2010 May; 135(21):p21. PubMed ID: 20509110
[No Abstract] [Full Text] [Related]
27. Riociguat: a novel therapeutic option for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Mielniczuk LM; Swiston JR; Mehta S
Can J Cardiol; 2014 Oct; 30(10):1233-40. PubMed ID: 25154043
[TBL] [Abstract][Full Text] [Related]
28. Riociguat for interstitial lung disease and pulmonary hypertension: a pilot trial.
Hoeper MM; Halank M; Wilkens H; Günther A; Weimann G; Gebert I; Leuchte HH; Behr J
Eur Respir J; 2013 Apr; 41(4):853-60. PubMed ID: 22936711
[TBL] [Abstract][Full Text] [Related]
29. What is new about Rio?
Souza R; Kawut SM
Eur Respir J; 2015 May; 45(5):1211-3. PubMed ID: 25931483
[No Abstract] [Full Text] [Related]
30. [Systemic sclerosis - an update].
Bergmann C; Distler JH
Dtsch Med Wochenschr; 2015 Apr; 140(7):504-7. PubMed ID: 25826034
[No Abstract] [Full Text] [Related]
31. Novel medical therapies for pulmonary arterial hypertension.
O'Connell C; O'Callaghan DS; Humbert M
Clin Chest Med; 2013 Dec; 34(4):867-80. PubMed ID: 24267310
[TBL] [Abstract][Full Text] [Related]
32. Changing perceptions in pulmonary hypertension.
Gerges C; Lang IM
Lancet Respir Med; 2014 Jan; 2(1):21-3. PubMed ID: 24461891
[No Abstract] [Full Text] [Related]
33. Can natriuretic peptides help identify heart failure patients for whom statins are beneficial?
Daniels LB; Barrett-Connor E
J Am Coll Cardiol; 2009 Nov; 54(20):1860-1. PubMed ID: 19892236
[No Abstract] [Full Text] [Related]
34. Biological serum markers in the management of pediatric pulmonary arterial hypertension.
Van Albada ME; Loot FG; Fokkema R; Roofthooft MT; Berger RM
Pediatr Res; 2008 Mar; 63(3):321-7. PubMed ID: 18287971
[TBL] [Abstract][Full Text] [Related]
35. [The SERAPHIN study].
D'Alto M; Vitulo P
G Ital Cardiol (Rome); 2015 Jan; 16(1):6-10. PubMed ID: 25689745
[No Abstract] [Full Text] [Related]
36. Clinical research in pulmonary hypertension comes of age.
Barberà JA
Arch Bronconeumol; 2014 Nov; 50(11):463-4. PubMed ID: 24998025
[No Abstract] [Full Text] [Related]
37. Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs.
Evgenov OV; Ichinose F; Evgenov NV; Gnoth MJ; Falkowski GE; Chang Y; Bloch KD; Zapol WM
Circulation; 2004 Oct; 110(15):2253-9. PubMed ID: 15466650
[TBL] [Abstract][Full Text] [Related]
38. What should be the endpoints of a symptomatic drug and its control?
Leone G
Lancet Haematol; 2017 May; 4(5):e197-e198. PubMed ID: 28460814
[No Abstract] [Full Text] [Related]
39. [Pulmonary hypertension].
Kovacs G; Olschewski H
Dtsch Med Wochenschr; 2012 Oct; 137(40):2026-8. PubMed ID: 23023615
[No Abstract] [Full Text] [Related]
40. Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebo-controlled, dose-ranging hemodynamic study.
Bonderman D; Ghio S; Felix SB; Ghofrani HA; Michelakis E; Mitrovic V; Oudiz RJ; Boateng F; Scalise AV; Roessig L; Semigran MJ;
Circulation; 2013 Jul; 128(5):502-11. PubMed ID: 23775260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
